If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMurray Income Trust Regulatory News (MUT)

Share Price Information for Murray Income Trust (MUT)

Share Price is delayed by 15 minutes
Get Live Data
1,000.00    11.00 (1.11%)
Bid:
1,000.00
Ask:
1,004.00
Spread: 4.00 (0.40%)
Market Cap: £933.14m
MUT Live PriceLast checked at - London Stock Exchange

Intraday Murray Income Trust Share Chart

Reduction in Management Fee

30 Aug 2024 07:00

RNS Number : 2060C
Murray Income Trust PLC
30 August 2024
 

MURRAY INCOME TRUST PLC

Legal Entity Identifier (LEI): 549300IRNFGVQIQHUI13

 

30 August 2024

 

Reduction in Management Fee

Murray Income Trust PLC (the "Company") announces that it has reduced and simplified its investment management fee arrangements with abrdn Fund Managers Limited (the "Manager").

With effect from 1 July 2024, the annual investment management fee is calculated as 0.35% of the Company's net assets up to £1.1 billion and 0.25% of any net assets above £1.1 billion. Formerly, the fee was 0.55% on the first £350 million of net assets, 0.45% on net assets from £350 million to £450 million and 0.25% on any net assets in excess of £450 million.

Peter Tait, Chair, commented:

"I am very pleased to announce that the Board of Murray Income Trust PLC has come to an agreement with the Manager for a revised fee schedule to be applied from the beginning of the Company's current financial year, 1 July 2024. The headline fee rate will now be 0.35% on the first £1.1 billion of net assets in the portfolio. We believe that this is a competitive fee in the universe of UK equity income funds and should prove attractive to both existing and potential shareholders."

Enquiries:

For further information, please contact:

Stuart Reid

abrdn Holdings Limited

Secretaries

Email:  cef.cosec@abrdn.com

 

About the Company

 

Murray Income Trust PLC, established in 1923, is an investment trust aiming for high and growing income with capital growth through investment in a portfolio principally composed of UK equities. Managed by abrdn, a leading global asset management company, the Company has a market cap approaching £1 billion, is listed on the London Stock Exchange and is a constituent of the FTSE-250 Index.

 

The Company is recognised as a 'Dividend Hero' by the Association of Investment Companies, boasting a 51-year track record of annual dividend increases, making it an attractive choice for risk-averse income seekers. The Manager's investment process prioritises quality characteristics, targeting exceptional companies by thoroughly evaluating their management, finances, and business models first-hand. This rigorous approach aims to build a portfolio capable of delivering a high and growing income, with dividends paid quarterly.

 

The Manager employs a '3D' investment approach - dependable, diversified, and differentiated - to identify high-quality large-cap companies with robust earnings potential, as well as small and mid-cap companies with strong growth prospects. The ability to invest up to 20% of the portfolio in overseas-listed companies provides differentiation from peers.

 

The Board of the Company and the Manager believe that investment in the UK equity income sector offers a compelling opportunity, with investors increasingly recognising that dividends are a key driver of long-term total equity returns. Many areas of the UK market have seen dividends rebased and pay-out ratios remain modest, providing a strong foundation for dividend growth. The Manager's focus on quality companies gives investors access to predominantly global businesses capable of delivering appealing long-term earnings and dividend growth.

 

For more information, or to sign up for regular updates from the Company, please visit: www.murray-income.co.uk.

 

END

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDZGZRDLKGDZM
Date   Source Headline
12th Dec 202512:25 pmRNSNet Asset Value(s)
11th Dec 20255:08 pmRNSTransaction in Own Shares
11th Dec 202512:20 pmRNSNet Asset Value(s)
10th Dec 202512:36 pmRNSNet Asset Value(s)
9th Dec 20252:09 pmRNSPortfolio Disclosures
9th Dec 202512:20 pmRNSNet Asset Value(s)
8th Dec 20253:07 pmRNSGearing disclosure
8th Dec 202512:26 pmRNSNet Asset Value(s)
5th Dec 20255:07 pmRNSTransaction in Own Shares
5th Dec 202512:26 pmRNSNet Asset Value(s)
4th Dec 20251:00 pmRNSMonth End Net Asset Value(s)
4th Dec 202511:32 amRNSNet Asset Value(s)
3rd Dec 20255:17 pmRNSTransaction in Own Shares
3rd Dec 202511:52 amRNSNet Asset Value(s)
2nd Dec 202512:12 pmRNSNet Asset Value(s)
1st Dec 20252:15 pmRNSGearing Disclosures
1st Dec 20259:59 amRNSTotal Voting Rights
28th Nov 20255:22 pmRNSTransaction in Own Shares
28th Nov 202512:20 pmRNSNet Asset Value(s)
27th Nov 202512:28 pmRNSNet Asset Value(s)
26th Nov 20255:21 pmRNSTransaction in Own Shares
26th Nov 202512:20 pmRNSNet Asset Value(s)
25th Nov 20255:25 pmRNSTransaction in Own Shares
25th Nov 20254:00 pmRNSDirector/PDMR Shareholding
25th Nov 202512:22 pmRNSNet Asset Value(s)
24th Nov 20255:39 pmRNSTransaction in Own Shares
24th Nov 20254:09 pmRNSDirector/PDMR Shareholding
24th Nov 20251:17 pmRNSGearing disclosure
24th Nov 202512:33 pmRNSNet Asset Value(s)
21st Nov 20255:14 pmRNSTransaction in Own Shares
21st Nov 202512:49 pmRNSNet Asset Value(s)
21st Nov 20257:00 amRNSBlock listing Interim Review
20th Nov 20255:10 pmRNSTransaction in Own Shares
20th Nov 202512:28 pmRNSNet Asset Value(s)
20th Nov 20257:00 amRNSOutcome of Strategic Review
19th Nov 202511:10 amRNSNet Asset Value(s)
18th Nov 202512:25 pmRNSNet Asset Value(s)
17th Nov 20253:27 pmRNSGearing disclosure
17th Nov 202512:26 pmRNSNet Asset Value(s)
14th Nov 202512:30 pmRNSNet Asset Value(s)
14th Nov 20258:44 amRNSPortfolio disclosure
13th Nov 202511:58 amRNSNet Asset Value(s)
12th Nov 202510:48 amRNSNet Asset Value(s)
11th Nov 202510:56 amRNSNet Asset Value(s)
10th Nov 20252:35 pmRNSGearing disclosure
10th Nov 202512:31 pmRNSNet Asset Value(s)
7th Nov 202511:56 amRNSNet Asset Value(s)
6th Nov 202512:00 pmRNSMonth End Net Asset Value(s)
6th Nov 202510:13 amRNSNet Asset Value(s)
5th Nov 202511:28 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.